Skip to main content
. 2021 Oct;10(10):3826–3836. doi: 10.21037/tau-21-835

Table 4. All-cause, heart-related, and bladder-related mortality in patients with BCa who underwent RC, RT/RT + CT, or CT at diagnosis, analyzed by age and treatment subgroup.

Age Variables All causes Heart-specific disease BCa
HR P value SHR P value SHR P value
<50 Treatment
   RC
   RT/RT + CT 2.15 (1.78, 2.60) <0.001 1.62 (0.52, 5.12) 0.407 1.89 (1.50, 2.39) <0.001
   CT 1.39 (1.18, 1.64) <0.001 1.26 (0.52, 3.09) 0.609 1.34 (1.12, 1.61) 0.002
50–64 Treatment
   RC
   RT/RT + CT 1.84 (1.69, 2.00) <0.001 1.29 (0.83, 2.00) 0.261 1.67 (1.51, 1.86) <0.001
   CT 1.27 (1.18, 1.37) <0.001 1.00 (0.69, 1.46) 0.981 1.26 (1.16, 1.38) <0.001
65–74 Treatment
   RC
   RT/RT + CT 1.90 (1.76, 2.05) <0.001 1.59 (1.25, 2.02) <0.001 1.57 (1.43, 1.73) <0.001
   CT 1.17 (1.09, 1.26) <0.001 1.00 (0.79, 1.27) 0.995 1.20 (1.09, 1.31) <0.001
≥75 Treatment
   RC
   RT/RT + CT 1.98 (1.86, 2.10) <0.001 1.49 (1.25, 1.77) <0.001 1.62 (1.50, 1.75) <0.001
   CT 1.17 (1.10, 1.26) <0.001 1.38 (1.15, 1.66) 0.001 1.01 (0.93, 1.11) 0.754

BCa, bladder cancer; RC, radical cystectomy; RT, radiotherapy; CT, chemotherapy; HR, hazard ratio; SHR, sub-distribution hazard ratio.